DekaBank Deutsche Girozentrale - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 136 filers reported holding IMMUNITYBIO INC in Q2 2022. The put-call ratio across all filers is 1.87 and the average weighting 0.0%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$309
-41.4%
196,2000.0%0.00%0.0%
Q2 2023$527
+56.8%
196,2000.0%0.00%0.0%
Q1 2023$336
-64.7%
196,2000.0%0.00%
-66.7%
Q4 2022$951
-99.9%
196,2000.0%0.00%0.0%
Q3 2022$947,000
+30.8%
196,2000.0%0.00%
+50.0%
Q2 2022$724,000
-37.4%
196,2000.0%0.00%
-33.3%
Q1 2022$1,156,000
+344.6%
196,200
+367.1%
0.00%
+200.0%
Q4 2021$260,000
-33.2%
42,000
+2.4%
0.00%0.0%
Q3 2021$389,000
-32.6%
41,0000.0%0.00%
-50.0%
Q2 2021$577,00041,0000.00%
Other shareholders
IMMUNITYBIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
Winning Points Advisors, LLC 251,556$1,387,0001.70%
ORACLE INVESTMENT MANAGEMENT INC 315,322$1,567,0000.89%
HARBOURVEST PARTNERS LLC 335,709$1,668,0000.54%
ALLEN HOLDING INC /NY 687,571$3,417,0000.54%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$479,0000.21%
SHEETS SMITH WEALTH MANAGEMENT 207,926$1,033,0000.17%
Clearwater Capital Advisors, LLC 185,911$924,0000.13%
WEALTH EFFECTS LLC 28,500$142,0000.09%
Virtus ETF Advisers LLC 35,048$174,0000.07%
Vident Investment Advisory, LLC 195,127$969,0000.03%
View complete list of IMMUNITYBIO INC shareholders